Fabrice Andre, MD, PhD | Authors

Articles

Using Platinum Agents in Different Settings of TNBC

April 24, 2018

Fabrice André, MD, PhD, professor in the Department of Medical Oncology at the Institut Gustave Roussy in Villejuif, France, addresses questions regarding the use of platinum regimens for patients with triple-negative breast cancer (TNBC). He discusses 2 platinum agents, cisplatin and carboplatin, and when it is recommended that these agents be used.